Efficacy, safety and cost of new drugs acting on the central nervous system-Reference-Cited by-同舟云学术

Efficacy, safety and cost of new drugs acting on the central nervous system

Published:2003-03-22 Issue:1 Volume:59 Page:79-84
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Garattini Silvio,Bertele' Vittorio

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00228-003-0569-3.pdf

Reference28 articles.

1. Garattini S, Bertele' V (2002) Efficacy, safety, and cost of new anticancer drugs. BMJ 325:269–271

2. EMEA (1999) Final opinion of the Committee for Proprietary Medicinal Products on the refusal of a marketing authorisation for Kronos. http://www.emea.eu.int/pdfs/human/opinion/06779en.pdf

3. EMEA (2001) Public statement on the recommendation to suspend the marketing authorisation for Orlaam (levacetylmethadol) in the European Union. http://www.emea.eu.int/pdfs/human/press/pus/877601en.pdf

4. Ruottinen HM, Rinne UK (1996) A double-blind pharmacokinetic and clinical dose-response study of entacapone as an adjuvant to levodopa therapy in advanced Parkinson's disease. Clin Neuropharmacol 19:283–296

5. Rinne UK, Larsen JP, Siden A, Worm-Petersen J (1998) Entacapone enhances the response to levodopa in parkinsonian patients with motor fluctuations. Neurology 51:1309–1314

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 20-Week intramuscular toxicity study of rotigotine behenate extended-release microspheres for injection via intramuscular injection in cynomolgus monkeys;Food and Chemical Toxicology;2024-08

2. Why the drug development pipeline is not delivering better medicines;BMJ;2015-10-23

3. A New Approach to Psychiatric Drug Approval in Europe;PLoS Medicine;2013-10-15

4. Improving the prediction of the brain disposition for orally administered drugs using BDDCS;Advanced Drug Delivery Reviews;2012-01

5. Does the development of new medicinal products in the European Union address global and regional health concerns?;Population Health Metrics;2010-12